These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14829463)

  • 1. Sickle cell disease: studies on "in vivo" sickling and the effect of certain pharmacological agents.
    HENDERSON AB
    Am J Med Sci; 1951 Jun; 221(6):628-35. PubMed ID: 14829463
    [No Abstract]   [Full Text] [Related]  

  • 2. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
    Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oxygen tension and of pH on the sickling and mechanical fragility of erythrocytes from patients with sickle cell anemia and the sickle cell trait.
    LANGE RD; MINNICH V; MOORE CV
    J Lab Clin Med; 1951 May; 37(5):789-802. PubMed ID: 14841422
    [No Abstract]   [Full Text] [Related]  

  • 4. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sickle cell anemia].
    Sugihara T
    Nihon Rinsho; 1996 Sep; 54(9):2442-7. PubMed ID: 8890576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sickle cell anemia in a patient heterozygous in respect to the sickling trait].
    GADDINI DE BENEDETTI R
    Minerva Pediatr; 1956 Nov; 8(44):1357-66. PubMed ID: 13387420
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood-oxygen affinity and sickling in sickle cell disease: effect of prior deoxygenation.
    Sinet M; Pocidalo JJ
    J Lab Clin Med; 1981 Oct; 98(4):492-9. PubMed ID: 6793678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sickle cell anemia and the affinity of the blood for oxygen].
    Pocidalo JJ; Sinet M
    C R Seances Soc Biol Fil; 1979; 173(2):303-13. PubMed ID: 159755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-sickling effect of dietary thiocyanate in prophylactic control of sickle cell anemia.
    Agbai O
    J Natl Med Assoc; 1986 Nov; 78(11):1053-6. PubMed ID: 3795284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
    Roth E; Elbaum D; Godoy E; Nagel RL
    Nouv Rev Fr Hematol (1978); 1979 Jan; 20(4):611-9. PubMed ID: 440964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell anemia in Garasia tribals of Rajasthan.
    Mandot S; Khurana VL; Sonesh JK
    Indian Pediatr; 2009 Mar; 46(3):239-40. PubMed ID: 19179738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell shape and structure: images and concepts (1840-1980).
    Bessis M; Delpech G
    Blood Cells; 1982; 8(2):359-435. PubMed ID: 6760930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anticoagulant preparations on the sickling phenomenon.
    UPSHAW CB; WILLIS PW
    J Natl Med Assoc; 1962 Jul; 54(4):445-50. PubMed ID: 13923858
    [No Abstract]   [Full Text] [Related]  

  • 15. Monovalent cation changes in sickle erythrocytes: a direct reflection of alpha-globin gene number.
    Embury SH; Backer K; Glader BE
    J Lab Clin Med; 1985 Jul; 106(1):75-9. PubMed ID: 4009025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal hemoglobins; clinical disorders resulting from various combinations.
    LAWRENCE JS; VALENTINE WN
    Calif Med; 1955 Jan; 82(1):1-5. PubMed ID: 13230906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies in sickle cell anemia; effect of age (maturation) on incidence of the sickling phenomenon.
    SCOTT RB; FREEMAN LC; FERGUSON AD
    Pediatrics; 1954 Sep; 14(3):209-14. PubMed ID: 13194328
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of pH, on the sickling phenomenon and its therapeutic possibilities.
    HADDAD RJ; DEBARDELEBEN PC
    Bull Tulane Univ Med Fac; 1956 Aug; 15(4):165-72. PubMed ID: 13342920
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
    Roth E; Elbaum D; Godoy E; Nagel RL
    Nouv Rev Fr Hematol (1978); 1978; 20(4):611-9. PubMed ID: 752153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse.
    Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL
    J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.